or Try an Advanced Search...

    Technical Analysis for ONVO - Organovo Holdings, Inc.

    Grade Last Price % Change Price Change
    F 0.76 -0.34% 0.00
    ONVO closed down 0.34 percent on Monday, July 1, 2024, on 11 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical ONVO trend table...
    Date Alert Name Type % Chg
    NR7 Range Contraction 0.00%
    NR7-2 Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Inside Day Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    NR7 Range Contraction -0.34%
    NR7-2 Range Contraction -0.34%
    Narrow Range Bar Range Contraction -0.34%
    Wide Bands Range Expansion -0.34%
    Older End-of-Day Signals for ONVO ...

       Recent Intraday Alerts

    Alert Time
    Up 2% about 6 hours ago
    Up 1% about 6 hours ago
    Possible NR7 about 6 hours ago
    Possible Inside Day about 6 hours ago
    Up 1% 3 days ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    ONVO Chart by TradingView
    Basic chart:

    Profile

    Organovo Holdings, Inc. develops three-dimensional (3D) bioprinting technology for creating functional human tissues on demand for research and medical applications. The company's 3D NovoGen bioprinting technology works across various tissue and cell types, and allows for the placement of cells in desired pattern. It offers NovoGen MMX Bioprinter, a commercial hardware and software bioprinter platform to create tissues for bioprinting research and development. The company was founded in 2007 and is based in San Diego, California.
    Classification
    Sector: Healthcare
    Industry: Diagnostics & Research
    Keywords: Biotechnology Biology Synthetic Biology Medical Applications Novogen Printing Technology Tissue Engineering

    Is ONVO a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 4 ONVO Increases Cash and Improves Prospects
    May 21 Organovo Data Presented at Digestive Disease Week (DDW2024) Demonstrating Potential for FXR314 as Combination Therapy with Tofacitinib for Inflammatory Bowel Disease
    May 14 Organovo to Present Data on FXR314 at Digestive Diseases Week (DDW2024)
    May 9 Organovo Holdings, Inc. Announces Pricing of $5.25 Million Public Offering
    May 1 ONVO Announces Very Positive Phase 2 Results
    Apr 15 Why Organovo Stock Is Up Today
    Apr 15 Organovo reports positive mid-stage results for FXR314 in metabolic dysfunction-associated steatohepatitis
    Apr 15 Organovo Announces Positive Phase 2 Results for FXR314 in Metabolic Dysfunction-Associated Steatohepatitis (MASH) Showing Both Reduction in Liver Fat Content and Strong Safety and Tolerability Compared to Placebo
    Apr 15 Why Medical Properties Trust Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
    Apr 12 Organovo files to sell common stock, warrants
    See more ONVO news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 2.05
    52 Week Low 0.725
    Average Volume 162,898
    200-Day Moving Average 1.10
    50-Day Moving Average 0.95
    20-Day Moving Average 0.88
    10-Day Moving Average 0.80
    Average True Range 0.06
    RSI (14) 29.58
    ADX 26.12
    +DI 18.40
    -DI 22.93
    Chandelier Exit (Long, 3 ATRs) 0.93
    Chandelier Exit (Short, 3 ATRs) 0.89
    Upper Bollinger Bands 1.07
    Lower Bollinger Band 0.70
    Percent B (%b) 0.17
    BandWidth 42.05
    MACD Line -0.06
    MACD Signal Line -0.05
    MACD Histogram -0.0125
    Fundamentals Value
    Market Cap 7.63 Million
    Num Shares 10 Million
    EPS -2.15
    Price-to-Earnings (P/E) Ratio -0.35
    Price-to-Sales 41.53
    Price-to-Book 1.07
    PEG Ratio 0.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.79
    Resistance 3 (R3) 0.80 0.79 0.79
    Resistance 2 (R2) 0.79 0.78 0.79 0.79
    Resistance 1 (R1) 0.77 0.77 0.77 0.77 0.78
    Pivot Point 0.76 0.76 0.76 0.76 0.76
    Support 1 (S1) 0.75 0.76 0.75 0.75 0.74
    Support 2 (S2) 0.74 0.75 0.74 0.73
    Support 3 (S3) 0.73 0.74 0.73
    Support 4 (S4) 0.73